Treating diseases with cord blood: ethical stem-cell process gets FDA approval – St.Louis Review
|
Treating diseases with cord blood: ethical stem–cell process gets FDA approval
St.Louis Review Formerly regarded as an investigational new drug, the FDA now classifies and regulates cord-blood stem–cell products used for these treatments as biologic drugs. “Cord blood differs from pharmaceutical drugs in that each collected unit has its own … |
